Osbon Capital Management’s Merck MRK Stock Holding History

Osbon Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$279K	Hold	2,171	–	–	0.22%	54
2026 Q1	$261K	Buy	2,171 +2,002	+1,185%	+$231K	0.21%	60
2025 Q4	$17.8K	Buy	+169	New	+$15.9K	0.02%	189

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Osbon Capital Management's MRK Position: Q2 2026 in Review

Osbon Capital Management held its Merck (MRK) position steady in Q2 2026 at 2,171 shares worth $279K. The position accounts for 0.22% of the portfolio, ranked #54.

Osbon Capital Management first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 3,841 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Osbon Capital Management held 2,171 shares of Merck worth $279K as of Q2 2026.
Osbon Capital Management left its Merck share count unchanged in Q2 2026.
Merck made up 0.22% of Osbon Capital Management's portfolio in Q2 2026, its #54 holding.
Osbon Capital Management first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
3,841 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Osbon Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.